Search results
9 paź 2024 · Cancer and COVID-19. Adults and children living with noncommunicable diseases (NCDs) are more at risk of severe consequences from coronavirus disease (COVID-19). As the COVID-19 pandemic evolves, proper planning is needed to mitigate its effects on people living with NCDs and its potential to increase illness, disability and avoidable deaths.
3 cze 2022 · Patients with cancer are at high risk of adverse outcomes associated with COVID-19, and this is particularly true for those patients who receive B-cell–depleting therapy. Immunotherapy with ICIs is not associated with adverse outcomes of COVID-19.
13 gru 2020 · The SARS-CoV-2 (COVID-19) pandemic has particularly serious consequences for cancer patients, as they are at high risk for severe complications and mortality due to the virus since cancer patients are immunocompromised.
22 lut 2024 · The ongoing COVID-19 pandemic has impacted health systems globally and affected managing many chronic conditions, including cancer. This study aimed to explore the perceptions of multi-disciplinary cancer care providers on how cancer pain management was affected by the COVID-19 pandemic. Methods.
20 cze 2020 · Data on patients with COVID-19 who have cancer are lacking. Here we characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify potential prognostic factors for mortality and severe illness. Methods.
1 wrz 2024 · At a glance. CDC offered guidance on how people with cancer can lower their risk of getting COVID-19, shared stories of cancer survivors who were diagnosed and treated during the pandemic and conducted research to find out how the pandemic affected cancer screening.
24 lip 2021 · Hypoxia is found to be an indicator of poor prognosis in both cancer and severe COVID-19. In breast cancer, hypoxia plays an important role in the activation of genes responsible for dormancy, stemness, epithelial-to-mesenchymal transition (EMT), and drug resistance and helps in the production of DBCCs.
